Starget Pharma
Novel Somatostatin-based Targeted Therapy Platform
Startup Seed Health Tech & Life Sciences Est. 2019
Total Raised
$15.1M
Seed
Last Round
$5.1M
2 rounds
Investors
2
2 public
Team
3
11-50 employees
Confidence
89/100
News
2
articles
About
Starget Pharma is focused on creating products for the diagnosis and targeted treatment of cancer through the use of targeted radiotherapy. The company develops molecules that serve as a vector for selectively transferring imaging materials and treatments directly to tumor tissue.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTest Diagnostics & Screening
Core Technology
BiologicalsMolecules
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
cancer-therapypeptidespharmaceuticalsdiagnosticsbiotechnology
Funding & Events
Oct 2024
Undisclosed Round $5.1M
Cancer Focus Fund (Lead)
Dec 2019
Undisclosed Round $10M
Undisclosed Investor(s)
News (2)
Oct 28, 2024 ยท www.finsmes.com
growth-positive
Starget Pharma Receives $5.1M Investment From Cancer Focus Fund
Investment
Nov 14, 2021 ยท www.globes.co.il
growth-positive
ืื™ืœืงืก ืžื“ื™ืงืœ ืžืฉืงื™ืขื” 10 ืžื™ืœื™ื•ืŸ ื“' ื‘ืกื˜ืืจื˜-ืืค ืœืื‘ื—ื•ืŸ ื•ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ
Investment
Details
Product Stage
R&D
Employees
11-50
Exact Count
18
District
Center District
Founded
2019
Registrar
516057411
Crunchbase
starget-pharma-ltd
Locations
Ramat Hasharon, Israel
Links
Website
LinkedIn
Admin
Last Update
Jan 7, 2025
Verified by
Yotam Maman
Missing
video or image, markets, not claimed
Team (3)
Sigal Kalmanson Cusnir
Co-founder & CEO
Founder
Ronen Kalmanson
Co-founder
Founder
Mor Oron-Herman
Vice President Research & Development
Internal
Created by
Yanina Wainscheinker (yanina.wain@gmail.com)
Created
2021-11-17T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)